Goldman Sachs Group Inc Artivion, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 185,697 shares of AORT stock, worth $4.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
185,697
Previous 167,257
11.02%
Holding current value
$4.96 Million
Previous $4.29 Million
15.22%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AORT
# of Institutions
175Shares Held
36MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$177 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$74.8 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$74.6 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$73.3 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$65.4 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.08B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...